Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: TechNavio | PRODUCT CODE: 1743436

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1743436

Global Hospital Infection Therapeutics Market 2025-2029

PUBLISHED:
PAGES: 231 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Description

Table of Contents

List of Tables

The hospital infection therapeutics market is forecasted to grow by USD 3,786.3 mn during 2024-2029, accelerating at a CAGR of 5.5% during the forecast period. The report on the hospital infection therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence and prevalence of respiratory disorders, growing geriatric population, and special drug designations.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20255.1%
CAGR5.5%
Incremental Value$3,786.3 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's hospital infection therapeutics market is segmented as below:

By Drug Class

    • Antibiotics drugs
    • Antifungal drugs
    • Antiviral drugs

By Type

    • Respiratory tract infections
    • Surgical site infections
    • Bloodstream infections
    • Gastrointestinal infections
    • Urinary tract infections

By End-user

    • Hospitals
    • Ambulatory surgical centers
    • Specialty clinics
    • Long-term care facilities

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increasing hospital visits as one of the prime reasons driving the hospital infection therapeutics market growth during the next few years. Also, unmet needs in developing countries and increasing demand for infection control committees in hospitals will lead to sizable demand in the market.

The report on the hospital infection therapeutics market covers the following areas:

    • Hospital Infection Therapeutics Market sizing
    • Hospital Infection Therapeutics Market forecast
    • Hospital Infection Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hospital infection therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Basilea Pharmaceutica Ltd., Bayer AG, Bristol Myers Squibb Co., Cipla Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Spero Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the hospital infection therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Show more
Product Code: IRTNTR75007

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Hospital Infection Therapeutics Market 2019 - 2023
    • Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2019 - 2023 ($ million)
  • 5.2 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.3 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global Hospital Infection Therapeutics Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Drug Class

  • 8.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 8.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 8.3 Antibiotics drugs - Market size and forecast 2024-2029
    • Chart on Antibiotics drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on Antibiotics drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on Antibiotics drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on Antibiotics drugs - Year-over-year growth 2024-2029 (%)
  • 8.4 Antifungal drugs - Market size and forecast 2024-2029
    • Chart on Antifungal drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on Antifungal drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on Antifungal drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on Antifungal drugs - Year-over-year growth 2024-2029 (%)
  • 8.5 Antiviral drugs - Market size and forecast 2024-2029
    • Chart on Antiviral drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on Antiviral drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on Antiviral drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on Antiviral drugs - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

9 Market Segmentation by Type

  • 9.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 9.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 9.3 Respiratory tract infections - Market size and forecast 2024-2029
    • Chart on Respiratory tract infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Respiratory tract infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Respiratory tract infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Respiratory tract infections - Year-over-year growth 2024-2029 (%)
  • 9.4 Surgical site infections - Market size and forecast 2024-2029
    • Chart on Surgical site infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Surgical site infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Surgical site infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Surgical site infections - Year-over-year growth 2024-2029 (%)
  • 9.5 Bloodstream infections - Market size and forecast 2024-2029
    • Chart on Bloodstream infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Bloodstream infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Bloodstream infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Bloodstream infections - Year-over-year growth 2024-2029 (%)
  • 9.6 Gastrointestinal infections - Market size and forecast 2024-2029
    • Chart on Gastrointestinal infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Gastrointestinal infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Gastrointestinal infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Gastrointestinal infections - Year-over-year growth 2024-2029 (%)
  • 9.7 Urinary tract infections - Market size and forecast 2024-2029
    • Chart on Urinary tract infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Urinary tract infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Urinary tract infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Urinary tract infections - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 10.4 Ambulatory surgical centers - Market size and forecast 2024-2029
    • Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
    • Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
    • Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • 10.5 Specialty clinics - Market size and forecast 2024-2029
    • Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • 10.6 Long-term care facilities - Market size and forecast 2024-2029
    • Chart on Long-term care facilities - Market size and forecast 2024-2029 ($ million)
    • Data Table on Long-term care facilities - Market size and forecast 2024-2029 ($ million)
    • Chart on Long-term care facilities - Year-over-year growth 2024-2029 (%)
    • Data Table on Long-term care facilities - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.13 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.14 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.15 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.6 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 15.7 Basilea Pharmaceutica Ltd.
    • Basilea Pharmaceutica Ltd. - Overview
    • Basilea Pharmaceutica Ltd. - Product / Service
    • Basilea Pharmaceutica Ltd. - Key offerings
    • SWOT
  • 15.8 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 15.9 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
    • SWOT
  • 15.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.11 Gilead Sciences Inc.
    • Gilead Sciences Inc. - Overview
    • Gilead Sciences Inc. - Product / Service
    • Gilead Sciences Inc. - Key news
    • Gilead Sciences Inc. - Key offerings
    • SWOT
  • 15.12 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.13 Johnson and Johnson Services Inc
    • Johnson and Johnson Services Inc - Overview
    • Johnson and Johnson Services Inc - Business segments
    • Johnson and Johnson Services Inc - Key news
    • Johnson and Johnson Services Inc - Key offerings
    • Johnson and Johnson Services Inc - Segment focus
    • SWOT
  • 15.14 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 15.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.17 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.18 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
Show more
Product Code: IRTNTR75007

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Drug Class
  • Exhibits41: Data Table on Comparison by Drug Class
  • Exhibits42: Chart on Antibiotics drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Antibiotics drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Antibiotics drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Antibiotics drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Antifungal drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Antifungal drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Antifungal drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Antifungal drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Antiviral drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Antiviral drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Antiviral drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Antiviral drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Market opportunity by Drug Class ($ million)
  • Exhibits55: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits56: Chart on Type - Market share 2024-2029 (%)
  • Exhibits57: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits58: Chart on Comparison by Type
  • Exhibits59: Data Table on Comparison by Type
  • Exhibits60: Chart on Respiratory tract infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Respiratory tract infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Respiratory tract infections - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Respiratory tract infections - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Surgical site infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Surgical site infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Surgical site infections - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Surgical site infections - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Bloodstream infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Bloodstream infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Bloodstream infections - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Bloodstream infections - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Gastrointestinal infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Gastrointestinal infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Gastrointestinal infections - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Gastrointestinal infections - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Chart on Urinary tract infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits77: Data Table on Urinary tract infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Chart on Urinary tract infections - Year-over-year growth 2024-2029 (%)
  • Exhibits79: Data Table on Urinary tract infections - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Market opportunity by Type ($ million)
  • Exhibits81: Data Table on Market opportunity by Type ($ million)
  • Exhibits82: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits83: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits84: Chart on Comparison by End-user
  • Exhibits85: Data Table on Comparison by End-user
  • Exhibits86: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Chart on Long-term care facilities - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Data Table on Long-term care facilities - Market size and forecast 2024-2029 ($ million)
  • Exhibits100: Chart on Long-term care facilities - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Data Table on Long-term care facilities - Year-over-year growth 2024-2029 (%)
  • Exhibits102: Market opportunity by End-user ($ million)
  • Exhibits103: Data Table on Market opportunity by End-user ($ million)
  • Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits107: Chart on Geographic comparison
  • Exhibits108: Data Table on Geographic comparison
  • Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Market opportunity By Geographical Landscape ($ million)
  • Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits167: Impact of drivers and challenges in 2024 and 2029
  • Exhibits168: Overview on criticality of inputs and factors of differentiation
  • Exhibits169: Overview on factors of disruption
  • Exhibits170: Impact of key risks on business
  • Exhibits171: Companies covered
  • Exhibits172: Company ranking index
  • Exhibits173: Matrix on companies position and classification
  • Exhibits174: Abbott Laboratories - Overview
  • Exhibits175: Abbott Laboratories - Business segments
  • Exhibits176: Abbott Laboratories - Key news
  • Exhibits177: Abbott Laboratories - Key offerings
  • Exhibits178: Abbott Laboratories - Segment focus
  • Exhibits179: SWOT
  • Exhibits180: AbbVie Inc. - Overview
  • Exhibits181: AbbVie Inc. - Product / Service
  • Exhibits182: AbbVie Inc. - Key news
  • Exhibits183: AbbVie Inc. - Key offerings
  • Exhibits184: SWOT
  • Exhibits185: AstraZeneca Plc - Overview
  • Exhibits186: AstraZeneca Plc - Product / Service
  • Exhibits187: AstraZeneca Plc - Key news
  • Exhibits188: AstraZeneca Plc - Key offerings
  • Exhibits189: SWOT
  • Exhibits190: Basilea Pharmaceutica Ltd. - Overview
  • Exhibits191: Basilea Pharmaceutica Ltd. - Product / Service
  • Exhibits192: Basilea Pharmaceutica Ltd. - Key offerings
  • Exhibits193: SWOT
  • Exhibits194: Bayer AG - Overview
  • Exhibits195: Bayer AG - Business segments
  • Exhibits196: Bayer AG - Key news
  • Exhibits197: Bayer AG - Key offerings
  • Exhibits198: Bayer AG - Segment focus
  • Exhibits199: SWOT
  • Exhibits200: Bristol Myers Squibb Co. - Overview
  • Exhibits201: Bristol Myers Squibb Co. - Product / Service
  • Exhibits202: Bristol Myers Squibb Co. - Key news
  • Exhibits203: Bristol Myers Squibb Co. - Key offerings
  • Exhibits204: SWOT
  • Exhibits205: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits206: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits207: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits208: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits209: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits210: SWOT
  • Exhibits211: Gilead Sciences Inc. - Overview
  • Exhibits212: Gilead Sciences Inc. - Product / Service
  • Exhibits213: Gilead Sciences Inc. - Key news
  • Exhibits214: Gilead Sciences Inc. - Key offerings
  • Exhibits215: SWOT
  • Exhibits216: GlaxoSmithKline Plc - Overview
  • Exhibits217: GlaxoSmithKline Plc - Business segments
  • Exhibits218: GlaxoSmithKline Plc - Key news
  • Exhibits219: GlaxoSmithKline Plc - Key offerings
  • Exhibits220: GlaxoSmithKline Plc - Segment focus
  • Exhibits221: SWOT
  • Exhibits222: Johnson and Johnson Services Inc - Overview
  • Exhibits223: Johnson and Johnson Services Inc - Business segments
  • Exhibits224: Johnson and Johnson Services Inc - Key news
  • Exhibits225: Johnson and Johnson Services Inc - Key offerings
  • Exhibits226: Johnson and Johnson Services Inc - Segment focus
  • Exhibits227: SWOT
  • Exhibits228: Merck and Co. Inc. - Overview
  • Exhibits229: Merck and Co. Inc. - Business segments
  • Exhibits230: Merck and Co. Inc. - Key news
  • Exhibits231: Merck and Co. Inc. - Key offerings
  • Exhibits232: Merck and Co. Inc. - Segment focus
  • Exhibits233: SWOT
  • Exhibits234: Novartis AG - Overview
  • Exhibits235: Novartis AG - Business segments
  • Exhibits236: Novartis AG - Key news
  • Exhibits237: Novartis AG - Key offerings
  • Exhibits238: Novartis AG - Segment focus
  • Exhibits239: SWOT
  • Exhibits240: Pfizer Inc. - Overview
  • Exhibits241: Pfizer Inc. - Product / Service
  • Exhibits242: Pfizer Inc. - Key news
  • Exhibits243: Pfizer Inc. - Key offerings
  • Exhibits244: SWOT
  • Exhibits245: Sanofi SA - Overview
  • Exhibits246: Sanofi SA - Business segments
  • Exhibits247: Sanofi SA - Key news
  • Exhibits248: Sanofi SA - Key offerings
  • Exhibits249: Sanofi SA - Segment focus
  • Exhibits250: SWOT
  • Exhibits251: Viatris Inc. - Overview
  • Exhibits252: Viatris Inc. - Business segments
  • Exhibits253: Viatris Inc. - Key news
  • Exhibits254: Viatris Inc. - Key offerings
  • Exhibits255: Viatris Inc. - Segment focus
  • Exhibits256: SWOT
  • Exhibits257: Inclusions checklist
  • Exhibits258: Exclusions checklist
  • Exhibits259: Currency conversion rates for US$
  • Exhibits260: Research methodology
  • Exhibits261: Information sources
  • Exhibits262: Data validation
  • Exhibits263: Validation techniques employed for market sizing
  • Exhibits264: Data synthesis
  • Exhibits265: 360 degree market analysis
  • Exhibits266: List of abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!